<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="187">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04382235</url>
  </required_header>
  <id_info>
    <org_study_id>WARd-COVID</org_study_id>
    <nct_id>NCT04382235</nct_id>
  </id_info>
  <brief_title>Non-invasive Ventilatory Support of Patients Affected by COVID-19</brief_title>
  <acronym>WARd-COVID</acronym>
  <official_title>Management Through Non-invasive Ventilatory Support of Patients Showing an Acute Respiratory Failure Related to COVID-19 in Non-intensive Wards</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Milano Bicocca</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Milano Bicocca</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, observational, multicenter study aiming to evaluate the number of COVID-19
      pneumonia related patients treated with non-invasive ventilatory support outside the
      intensive care unit.

      In addition, the study aims to obtain information related to the clinical characteristics and
      hospital results of these patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In February 2020, the first case of transmission of the syndrome, indicated as COVID-19, was
      reported in Italy. Unfortunately, during March 2020, the syndrome spread rapidly throughout
      the country, affecting tens of thousands of patients, including several thousands have
      requested hospitalization and some hospitalization in intensive care, putting a strain on the
      entire regional health system.

      Patients that present intermediate severity of the infection are often treated with
      non-invasive ventilatory support which includes high-flow nasal cannulas (HFNC), non-invasive
      ventilation (NIV), continuous positive airway pressure (CPAP) through face mask or helmet
      (helmet).

      The exponential growth in the number of patients has made the massive use of these devices
      necessary even outside the intensive or semi-intensive wards where they are traditionally
      used.

      Epidemiological knowledge regarding the type of patients treated with this strategy and the
      outcome of these patients are limited, but very important in a context of emergency.

      Thus, the objective of this prospective multicenter study is to evaluate the number of
      patients with COVID-19 related pneumonia, treated with non-invasive ventilatory support
      outside the intensive care unit and to evaluate the clinical characteristics and hospital
      outcomes of these patients.

      SAMPLE SIZE (n. Patients):

      The study will collect all patients with the inclusion criteria, so the study size being by
      definition equal to the maximum size.

      STUDY DESIGN:

      Patients will be enrolled on a single day (March 26, 2020 or March 31, 2020 chosen by the
      participating centres).

      Total duration of the Study: 5 months (enrollment, collection and analysis of data).

      Enrollment Start: March 26, 2020. Enrollment Closure: March 31, 2020. End of the Study
      (indicative date, last visit, last patient): May 2020.

      The patient will be enrolled in the study when informed consent is obtained.

      In this phase, the following data are collected:

        -  Patient registration;

        -  Demographic and anthropometric data;

        -  Comorbidity

        -  Hospitalization data;

        -  Ventilation / Hemodynamics data;

        -  Blood chemistry tests.

      Upon discharge other data will be collected such as the necessary intubation or intubation
      date.

      STATISTICAL ANALYSIS:

      The enrolled cases will be counted and the percentages of the three types of non-invasive
      ventilatory supports will be specifically described by centre. The heterogeneity of these
      percentages will be assessed through a model with mixed effects.

      The anamnestic and clinical data of the enrolled patients will be analysed through
      descriptive statistics on continuous quantitative variables.

      The impact of the type of ventilation and of the blood chemistry parameters and aspects of
      comorbidity will be assessed with reference to the probability of developing a transition to
      the death and to hospitalization in intensive care through a multinomial model.

      These factors will also be included in a logistic model with outcome defined by patient
      survival.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 26, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The number of patients treated with non-invasive ventilation devices.</measure>
    <time_frame>Until patient discharge from the hospital (approximately 5 months)</time_frame>
    <description>The first purpose of the study is to evaluate the number of COVID-19 related pneumonia patients treated with devices for non-invasive ventilation outside intensive care units.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of patients requiring mechanical ventilation</measure>
    <time_frame>Until patient discharge from the hospital (approximately 5 months)</time_frame>
    <description>Assess the clinical characteristics of patients treated with devices for non-invasive ventilation using the following endpoint: incidence of patients requiring mechanical ventilation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of organ failure</measure>
    <time_frame>Until patient discharge from the hospital (approximately 5 months)</time_frame>
    <description>Assess the clinical characteristics of patients treated with devices for non-invasive ventilation using the following endpoint: incidence of organ failure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospitalization</measure>
    <time_frame>Until patient discharge from the hospital (approximately 5 months)</time_frame>
    <description>Measure the hospital outcomes of patients treated with devices for non-invasive ventilation using the following endpoint: duration of hospitalization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical outcome at hospital discharge</measure>
    <time_frame>Until patient discharge from the hospital (approximately 5 months)</time_frame>
    <description>Measure the hospital outcomes of patients treated with devices for non-invasive ventilation using the following endpoint: clinical outcome at hospital discharge.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Covid-19</condition>
  <arm_group>
    <arm_group_label>Covid-19 related Pneumonia patients</arm_group_label>
    <description>The cohort is defined by subjects with a diagnosis of COVID 19-related pneumonia requiring non-invasive ventilatory support.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-invasive ventilatory support</intervention_name>
    <description>All non-invasive ventilatory support wll be recorded. All collected data is taken and monitored during normal clinical practice without adding any other tests.</description>
    <arm_group_label>Covid-19 related Pneumonia patients</arm_group_label>
    <other_name>High-flow nasal cannulas (HFNC)</other_name>
    <other_name>Non-invasive ventilation (NIV)</other_name>
    <other_name>Continuous positive airway pressure (CPAP) delivered with a face mask or helmet (helmet)</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study will be conducted on all patients diagnosed with COVID-related pneumonia in need
        of non-invasive ventilatory support. Patients will be enrolled on single day (March 26,
        2020 or March 31, 2020 chosen by the participating centers).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt; = 18 years

          -  Diagnosis of COVID-related pneumonia requiring non-invasive ventilatory support
             (high-flow nasal cannula, and / or non-invasive ventilation and / or CPAP)

        Exclusion Criteria:

        - Explicit refusal to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Policlinico San Marco - Ospedale Zingonia</name>
      <address>
        <city>Zingonia</city>
        <state>BG</state>
        <zip>24040</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Papa Giovanni XXIII - Bergamo</name>
      <address>
        <city>Bergamo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera - Universitaria di Bologna, Policlinico S. Orsola Malpighi</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Spedali Civili - Brescia</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Valle Olona - Ospedale di Busto Arsizio</name>
      <address>
        <city>Busto Arsizio</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Lariana - Ospedale Sant'Anna</name>
      <address>
        <city>Como</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Crema - Ospedale Maggiore di Crema</name>
      <address>
        <city>Crema</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Cremona - Ospedale di Cremona</name>
      <address>
        <city>Cremona</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto Clinico Humanitas Gavazzeni</name>
      <address>
        <city>Cremona</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Garda - Presidio di Desenzano del Garda</name>
      <address>
        <city>Desenzano Del Garda</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Monza - Desio</name>
      <address>
        <city>Desio</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Spedali Civili -Ospedale di Gardone Val Trompia</name>
      <address>
        <city>Gardone Val Trompia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Lecco - Ospedale &quot;A. Manzoni&quot;</name>
      <address>
        <city>Lecco</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Ovest milanese - Ospedale di Legnano</name>
      <address>
        <city>Legnano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Lodi - Ospedale Maggiore di Lodi</name>
      <address>
        <city>Lodi</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST OVEST Milanese - Ospedale di Magenta</name>
      <address>
        <city>Magenta</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Garda - Ospedale di Manerbio</name>
      <address>
        <city>Manerbio</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Mantova - Ospedale Carlo Poma</name>
      <address>
        <city>Mantova</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Melegnano e della Martesana - Presidio di Melzo-Gorgonzola</name>
      <address>
        <city>Melzo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Fatebenefratelli - Presidi Fatebenefratelli &amp; M. Melloni</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Fatebenefratelli - Sacco</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Grande Ospedale Metropolitano Niguarda</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS CÃ  Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Giuseppe</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Spedali Civili -Presidio Ospedaliero di Montichiari</name>
      <address>
        <city>Montichiari</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Monza - Ospedale San Gerardo</name>
      <address>
        <city>Monza</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Policlinico San Matteo - Pavia</name>
      <address>
        <city>Pavia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico San Pietro</name>
      <address>
        <city>Ponte San Pietro</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto Clinico Humanitas Rozzano</name>
      <address>
        <city>Rozzano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Valle Olona - Ospedale di Saronno</name>
      <address>
        <city>Saronno</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Bergamo OVEST - Ospedale &quot;Treviglio-Caravaggio&quot; di Treviglio</name>
      <address>
        <city>Treviglio</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Circolo e Fondazione Macchi - Varese</name>
      <address>
        <city>Varese</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Vimercate - Ospedale di Vimercate</name>
      <address>
        <city>Vimercate</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Melegnano e della Martesana - Ospedale di Vizzolo Predabissi</name>
      <address>
        <city>Vizzolo Predabissi</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.</citation>
    <PMID>31978945</PMID>
  </reference>
  <reference>
    <citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.</citation>
    <PMID>31986264</PMID>
  </reference>
  <reference>
    <citation>Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.</citation>
    <PMID>32091533</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 5, 2020</study_first_submitted>
  <study_first_submitted_qc>May 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2020</study_first_posted>
  <last_update_submitted>May 8, 2020</last_update_submitted>
  <last_update_submitted_qc>May 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronavirus</keyword>
  <keyword>sars-covid-2</keyword>
  <keyword>coronavirus infection</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

